Cargando…
Enhanced Antitumor Efficacy of a Combination of CPT‐11, a New Derivative of Camptothecin, and Cisplatin against Human Lung Tumor Xenografts
The objective of this study was to evaluate the antitumor efficacy of combined use of 7‐ethyl‐10‐[4‐(1‐piperidino)‐1‐piperidino]carhonyloxycamptothecin (CPT‐11) and cisplatin (CDDP). The antitumor activities of CPT‐11, CDDP and their combination against 3 human lung tumor xenografts were estimated u...
Autores principales: | Kudoh, Shinzoh, Takada, Minoru, Masuda, Noriyuki, Nakagawa, Kazuhiko, Itoh, Kazunobu, Kusunoki, Yohko, Negoro, Shun‐ichi, Matsui, Kaoru, Takifuji, Nobuhide, Morino, Hideo, Fukuoka, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919127/ https://www.ncbi.nlm.nih.gov/pubmed/8385085 http://dx.doi.org/10.1111/j.1349-7006.1993.tb02856.x |
Ejemplares similares
-
Relationship between the Pharmacokinetics of Irinotecan and Diarrhea during Combination Chemotherapy with Cisplatin
por: Kudoh, Shinzoh, et al.
Publicado: (1995) -
Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer
por: Masuda, Noriyuki, et al.
Publicado: (2010) -
Determinants of Myelosuppression in the Treatment of Non‐small Cell Lung Cancer with Cisplatin‐containing Chemotherapy
por: Matsui, Kaoru, et al.
Publicado: (1996) -
Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer.
por: Masuda, N., et al.
Publicado: (1993) -
Enhancement of Tumor Radio‐response by Irinotecan in Human Lung Tumor Xenografts
por: Tamura, Kenji, et al.
Publicado: (1997)